Interestingly, in melanoma and breast cancer xenograft models, loss of cathepsin L activity impaired tumor angiogenesis [19, 44], whereas in two independent models of PNET progression, loss of cathepsin L had no effect on the onset of tumor angiogenesis ([12] and this study). The gene discussed is CTSL; the disease is neoplasm.